Loading...
Belite Bio, Inc
BLTE•NASDAQ
Healthcare
Biotechnology
$64.81
$1.22(1.92%)
Belite Bio, Inc (BLTE) Financial Performance & Income Statement Overview
Review Belite Bio, Inc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-26.30%
↓ 26.30%
Net Income Growth
-14.26%
↓ 14.26%
Operating Cash Flow Growth
2.02%
↑ 2.02%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-32.07%
↓ 32.07%
ROIC
-29.85%
↓ 29.85%
Belite Bio, Inc (BLTE) Income Statement & Financial Overview
Review Belite Bio, Inc's (BLTE) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $7.25M | $6.84M | $9.08M | $6.76M |
| SG&A Expenses | $4.20M | $2.90M | $1.39M | $1.56M |
| Operating Expenses | $11.46M | $9.74M | $10.47M | $8.33M |
| Total Costs & Expenses | $11.46M | $9.74M | $10.47M | $8.33M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $34750.00 | $34750.00 |
| EBITDA | -$7.58M | -$9.74M | -$10.44M | -$8.29M |
| EBITDA Ratio | ||||
| Operating Income | -$11.46M | -$9.74M | -$10.47M | -$8.33M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $1.36M | $1.06M | $977000.00 | $463000.00 |
| Income Before Tax | -$10.10M | -$8.68M | -$9.49M | -$7.87M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $6000.00 |
| Net Income | -$10.10M | -$8.68M | -$9.49M | -$7.87M |
| Net Income Ratio | ||||
| EPS | -$0.33 | -$0.28 | -$0.31 | -$0.27 |
| Diluted EPS | -$0.33 | -$0.28 | -$0.31 | -$0.27 |
| Weighted Avg Shares Outstanding | $31.45M | $30.69M | $30.32M | $29.68M |
| Weighted Avg Shares Outstanding (Diluted) | $31.45M | $30.69M | $30.32M | $29.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan